Ally provides an AI‑driven heart health assessment that works directly from a smartphone. By guiding users through a specific breathing maneuver and capturing vascular responses via the phone’s camera on a fingertip, its machine‑learning model evaluates heart disease risk with 87‑91% accuracy and delivers personalized lifestyle recommendations.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals lack convenient, low-cost methods to assess their risk of cardiovascular disease, relying on infrequent clinical visits and expensive diagnostic equipment that are not accessible for routine monitoring.
Solution
Ally offers an AI-powered heart health assessment that runs on a standard smartphone. Users perform a guided breathing maneuver while the phone’s camera records vascular responses from a fingertip. A machine‑learning model analyzes these signals to estimate heart disease risk with 87‑91% accuracy. The app then provides personalized lifestyle recommendations to help users mitigate risk. Ongoing validation with thousands of participants, including a partnership with the Courtois Cardiovascular Signature Program, supports the clinical relevance of the technology.
Target Audience
Primary users are health‑conscious consumers seeking proactive cardiovascular screening, as well as healthcare providers, corporate wellness programs, and insurers looking for scalable, low‑cost heart risk assessment tools.
Features
- Smartphone-based measurement using the built‑in camera to capture fingertip pulse and vascular response during a specific breathing exercise
- Proprietary machine‑learning algorithm trained on a large dataset to classify heart health status with high accuracy
- Real‑time risk assessment delivered instantly on the device without the need for external hardware
- Personalized, AI‑generated lifestyle and prevention recommendations based on the assessment results
- Continuous validation through large‑scale studies and collaboration with established cardiovascular research programs